Databases and Knowledge Bases
PharmaInformatic develops ADME/Tox knowledge bases to optimise and accelerate drug discovery and development:
Preclinical And Clinical Trials Knowledge Base on Bioavailability (PACT-F):
The knowledge base has been used
PACT-F is the fundamental knowledge base to analyse the factors and conditions which influence bioavailability. It provides scientists with the results and knowledge of 100 years of bioavailability research in order to improve future drug design and drug development.
PharmaInformatic and BRIDGE BIORESEARCH sign cooperation agreement: Bioavailability prediction of drug candidates for treatment of Type 2 diabetes (more).
PharmaInformatic and UNIZYME LABORATORIES sign cooperation agreement: Selection and prioritisation of lead compounds for treatment of inflammatory diseases based on estimated oral bioavailability in humans with IMPACT-F (more).